|Bid||0.0100 x 0|
|Ask||0.0150 x 0|
|Day's Range||0.0100 - 0.0100|
|52 Week Range||0.0100 - 0.2000|
|Beta (5Y Monthly)||0.04|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec 28, 2016|
|1y Target Est||N/A|
Blackhawk Growth Corp. (CSE:BLR)(Frankfurt:0JJ) (the "Corporation" or "Blackhawk"), is pleased to showcase its upcoming health tech focused AI companies that will be acquired in the acquisition of Hardenbrook Group.
Blackhawk Growth Corp. ("Blackhawk") (CSE: BLR) (FSE: 0JJ) and MindBio Therapeutics Corp. (formerly, 1286409 B.C. Ltd.) ("MindBio") (together, the "Parties") are pleased to announce the completion of the previously announced plan of arrangement (the "Arrangement") pursuant to which Blackhawk completed a spin-out of the common shares of MindBio (each, a "MindBio Share").